Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.72
+0.44 (2.07%)
Nov 3, 2026, 11:51 AM EST - Market open
Privia Health Group Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Privia Health Group stock has a consensus rating of "Strong Buy" and an average price target of $31.47. The average 1-year stock price forecast is 44.89% higher than the current stock price, while the lowest is $24 (+10.50%) and the highest is $40 (+84.16%).
Price Target: $31.47 (+44.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 13 | 13 | 12 | 12 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 20 | 20 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $24 | Hold | Maintains | $24 | +10.50% | Nov 3, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $32 | Buy | Maintains | $32 | +47.33% | Nov 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $31 | Buy | Maintains | $31 | +42.73% | Oct 7, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $30 | Buy | Maintains | $30 | +38.12% | Sep 16, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $33 | Buy | Maintains | $33 | +51.93% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
2.46B
from 2.12B
Increased by 15.81%
Revenue Next Year
2.70B
from 2.46B
Increased by 9.73%
EPS This Year
0.89
from 0.99
Decreased by -10.40%
EPS Next Year
1.06
from 0.89
Increased by 19.84%
EPS and Forward PE are based on non-GAAP adjusted numbers.